Pharmaceutical Drug Delivery Market Scope And Analysis

  • Report Code : TIPRE00007628
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Pharmaceutical Drug Delivery Market Scope and Key Players Analysis by 2031

Buy Now

Pharmaceutical Drug Delivery Market Report Pharmaceutical Drug Delivery Market Size and Share Pharmaceutical Drug Delivery Market Scope and Analysis

Pharmaceutical Drug Delivery Market Report Scope

Report Attribute Details
Market size in 2023 US$ 1.74 billion
Market Size by 2031 US$ 3.15 billion
Global CAGR (2023 - 2031) 7.7%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Route of Administration
  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery
By Application
  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
By End User
  • Hospitals
  • Home Care Settings
  • ASC and Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc
  • Bayer AG
  • Johnson Johnson Services Inc
  • Novartis AG
  • 3M
  • BD
  • Sanofi
  • MERCK KGaA
  • GlaxoSmithKline plc
  • Antares Pharma

    • Pharmaceutical Drug Delivery Market News and Recent Developments

    The Pharmaceutical Drug Delivery Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for pharmaceutical drug delivery and strategies:

    • Stevanato Group collaborated with Recipharm to develop and manufacture pre-fillable syringes that would be integrated into a new soft mist inhaler for inhaling sensitive biological products. The new strategic collaboration aims to provide innovative primary packaging to pharmaceutical and biopharmaceutical companies using Recipharm’s proprietary soft mist inhalers. (Source: Stevanato Group, Company Website, 2023)
    • Coherus BioSciences, Inc has launched its UDENYCA on-body injector (OBI) utilizing the LTS Sorrel wearable drug delivery platform. UDENYCA (pegfilgrastim-cbqv) is a biosimilar pegfilgrastim administered the day after chemotherapy to decrease the incidence of infection as manifested by febrile neutropenia.  (Source: Cision US Ltd, Press Release, 2024)

    Pharmaceutical Drug Delivery Market Report Coverage and Deliverables

    The “Pharmaceutical Drug Delivery Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles